Cassava Sciences Inc (NASDAQ:SAVA) does about 1.67M shares in volume on a normal day but saw 7410906 shares change hands in the recent trading day. The company now has a market cap of 1.05B USD. Its current market price is $26.48, marking a decrease of -17.71% compared to the previous close of $32.18. The 52 week high reached by this stock is $42.20 whilst the lowest price level in 52 weeks is $8.79.
Cassava Sciences Inc (SAVA) has a 20-day trading average at $26.61 and the current price is -37.25% off the 52-week high compared with 201.25% distance from its 52-week low. The 50-day simple moving average of the closing price is $27.56 and its 200-day simple moving average is $22.96. If we look at the stock’s price movements over the week, volatility stands at 15.54%, which decreases to 8.97% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 48.47 to suggest the stock is neutral.
The consensus objective for the share price is $111.50, suggesting that the stock has a potential upside of 76.25% over the period.
FactSet Research has provided data showing that 2 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 0 analysts have rated it as a buy and 2 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on October 08, 2024 when H.C. Wainwright upgraded the stock to “Buy” and issued a price target of $116. B. Riley Securities downgraded its price target at $44.
The current price level is -0.49%, -3.90%, and 15.33% away from its SMA20, SMA50, and SMA200 respectively, with the SAVA price moving above the 50-day SMA on current market day. Cassava Sciences Inc (SAVA) stock is down -1.60% over the week and -2.97% over the past month. Its price is 17.64% year-to-date and 24.44% over the past year.
The stock last released its quarterly earnings report for quarter ended 9/30/2024, with the company’s earnings per share (EPS) of -0.5 below consensus estimates by -0.1. The company’s next earnings report forecasts estimating quarterly EPS at -0.36 and -1.24 for whole year.
To reach the target analysts have set, the stock logically needs to grow 76.25 percent from here.
The company has a return on investment of -10.60% and return on equity of -10.98%. The forward price to earnings ratio is 52.96. The beta has a value of -0.56. Price to book ratio is 7.62.
